{"id":10277,"date":"2006-09-03T23:28:24","date_gmt":"2006-09-03T21:28:24","guid":{"rendered":"http:\/\/www.fedaiisf.it\/entro-il-2010-superpillola\/"},"modified":"2006-09-03T23:28:24","modified_gmt":"2006-09-03T21:28:24","slug":"entro-il-2010-superpillola","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/entro-il-2010-superpillola\/","title":{"rendered":"By 2010 &#039;superpill&#039;"},"content":{"rendered":"<div>\n<div>The &#039;three-in-one&#039; pill to prevent heart attack and heart disease should arrive on the market between 2009 and 2010. And Spain will be the first country in the world where the drug will be available, which concentrates the generics of three widely used medicines: a statin to lower cholesterol, an antihypertensive and aspirin. The pill, which therefore acts on three fronts against some of the main risk factors for the heart, should be given to patients who have already suffered a heart attack to avoid a new attack. This was announced by the president of the World Heart Federation, Valentin Fuster, at the opening of the World Cardiology Congress in Barcelona - from Adnkronos salute 09.02.06<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Dovrebbe arrivare sul mercato fra il 2009 e il 2010 la pillola &#8216;tre in uno&#8217; per prevenire infarto e malattie cardiache. E la Spagna sar&#224; il primo Paese al mondo in cui sar&#224; disponibile il farmaco, che concentra i generici di tre medicinali molto utilizzati: una statina per abbassare il colesterolo, un antipertensivo e l&#8217;aspirina. &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-10277","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=10277"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10277\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=10277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=10277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=10277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}